Related Experiment Video
Updated: Jul 17, 2025

12:55
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
Published on: January 17, 2015
18.6K
Mammalian display to secretion switchable libraries for antibody preselection and high throughput functional
Ramona Gaa1, Hannah Melina Mayer1, Daniela Noack1
1NBE Technologies, Merck KGaA, Darmstadt, Germany.
Mabs
|August 30, 2023
Summary
This study combines mammalian libraries and microfluidic technology for enhanced therapeutic antibody discovery. The integrated workflow streamlines screening for potent antibody candidates with improved manufacturability.
Area of Science:
- Biotechnology
- Immunology
- Drug Discovery
Background:
- Mammalian libraries and microfluidic technologies are advancing therapeutic antibody discovery.
- Mammalian libraries preserve immune repertoires and facilitate bispecific antibody screening.
- Microfluidic methods enable rapid, high-content screening of antibody candidates.
Purpose of the Study:
- To explore the synergistic potential of combining microfluidic technologies with mammalian libraries for antibody discovery.
- To develop and validate integrated workflows for identifying optimal therapeutic antibody candidates.
- To demonstrate proof-of-concept for novel antibody discovery and optimization strategies.
Main Methods:
- Utilized antibody secretion, target co-expression, and reporter cell lines for bispecific antibody selection.
- Established a functional screen for antibody internalization, comparing autocrine and co-encapsulation methods.
- Implemented cell synchronization and a display-to-secretion switchable system for pre-enrichment and manufacturability sorting.
Main Results:
- Successfully selected in-trans acting agonistic bispecific antibodies.
- Identified autocrine one-cell approaches as advantageous for internalization screens.
- Demonstrated reduced assay variability through cell synchronization.
- Developed a system for pre-enriching antibody clones with high manufacturability.
Conclusions:
- The integration of microfluidic technologies and mammalian libraries is feasible for therapeutic antibody discovery.
- The developed workflows enable simultaneous screening for functional properties and manufacturability.
- This approach provides a foundation for optimizing the identification of superior therapeutic antibody candidates.

